Literature DB >> 1171896

Diurnal variation of plasma vasopressin in man.

C P George, F H Messerli, J Genest, W Nowaczynski, R Boucher, M Kuchel Orofo-Oftega.   

Abstract

Plasma arginine vasopressin (PAV) concentration was determined by radioimmunoassay during the diurnal cycle in 8 recombent healthy male subjects. Two subjects were studied again 3 weeks later while receiving 1 mycles. In 8 out of 10 cycles, a nocturnal increase in PAV was found; there was a progressive rise during the night in 5 subjects and a peak occurred at 2400 or 3400 h. In 1 subject no variation was detected and in another, the pattern was compleetly different. The mean PAV in the 10 cycles was significantly (P less than 0.001) higher during the night than during the day. Dexamethasone did not modify the pattern of variation, but induced a significant (P less than 0.001) decrease in PAV. Hematocrit remained stable throughout the study as did osmolality, except at 2000 h, when a significant (P less than 0.001) increase (5 mOsm) on average occurred in every subject. Blood sugar, sodium or chloride did not account for the observed rise in osmolality and no simultaneous change in PAV occurred. A rise in PAV explains, to some extent, the known nocturnal decrease in urine output. Diurnal variations in PAV must be taken into account in clinical investigations involving vasopressin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171896     DOI: 10.1210/jcem-41-2-332

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Desmopressin reduces night urine volume in geriatric patients: implication for treatment of the nocturnal incontinence.

Authors:  W O Seiler; H B Stähelin; U Hefti
Journal:  Clin Investig       Date:  1992-07

2.  Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.

Authors:  J H Evans; S R Meadow
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

3.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

4.  Circadian variations in plasma renin activity, catecholamines and aldosterone during exercise in women.

Authors:  L A Stephenson; M A Kolka; R Francesconi; R R Gonzalez
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

Review 5.  Desmopressin: in adults with nocturia.

Authors:  Risto S Cvetković; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Monosymptomatic nocturnal enuresis caused by seasonal temperature changes.

Authors:  Tuncay Tas; Basri Cakiroglu; Aydin Ismet Hazar; Mustafa Bahadir Can Balci; Orhun Sinanoglu; Yunus Nas; Fazli Yilmazer
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 7.  Clinical aspects of changes in water and sodium homeostasis in the elderly.

Authors:  Christian A Koch; Tibor Fulop
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

8.  Diurnal rhythms of plasma renin activity, atrial natriuretic peptide and arterial pressure during head-down bed rest in humans.

Authors:  G Gauquelin; A Maillet; A M Allevard; D Sigaudo; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  DDAVP and urine osmolality in refractory enuresis.

Authors:  S B Dimson
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

10.  Comparison of intranasal and oral desmopressin for nocturnal enuresis.

Authors:  A Fjellestad-Paulsen; S Wille; A S Harris
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.